Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study [0.03%]
中美食管癌的临床病理及治疗特征比较多中心医院基于研究
Juan Zhu,Lingbin Du,Huizhang Li et al.
Juan Zhu et al.
Background: Esophageal cancer (EC) remains a global health challenge due to its poor prognosis. China and the United States of America (USA) represent two distinct epicenters of EC burden. Understanding the EC disparities...
Immunological features of EGFR-mutant non-small cell lung cancer and clinical practice: a narrative review [0.03%]
EGFR突变型非小细胞肺癌的免疫学特征及其临床实践：综述研究
Yi Dong,Liaqat Khan,Yi Yao
Yi Dong
Immune checkpoint inhibitors (ICIs) have significantly improved outcomes for patients with advanced driver-negative non-small cell lung cancer (NSCLC). However, targeted therapy remains the preferred treatment for advanced driver-positive N...
Construction and application of a three-dimensional vascular variation-based nephrometry scoring system for completely endophytic renal tumors [0.03%]
基于三维血管变异的完全内生性肾肿瘤肾脏测量评分系统的构建与应用
Aihetaimujiang Anwaier,Xiangxian Che,Lei Shi et al.
Aihetaimujiang Anwaier et al.
Background: Completely endophytic renal tumors (CERT) pose significant challenges due to their anatomical complexity and loss of visual clues about tumor location. A facile scoring model based on three-dimensional (3D) re...
Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges [0.03%]
根除幽门螺旋杆菌以预防胃癌：进展和挑战
Zongchao Liu,Hengmin Xu,Weicheng You et al.
Zongchao Liu et al.
Gastric cancer remains a significant global health challenge, causing a substantial number of cancer-related deaths, particularly in China. While the exact causes of gastric cancer are still being investigated, Helicobacter pylori (H. pylor...
Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study [0.03%]
基于HPV整合状态的宫颈癌初筛风险评估及分诊策略：一项前瞻性队列研究5年随访结果
Xun Tian,Danhui Weng,Ye Chen et al.
Xun Tian et al.
Objective: We investigated the relation between man papillomavirus (HPV) integration status and the immediate risk of cervical intraepithelial neoplasia (CIN), as well as the triage strategy based on HPV integration test....
TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study [0.03%]
基于外泌体RNA衍生标志物预测透明细胞肾癌预后和免疫治疗应答的多队列研究
Aimin Jiang,Ying Liu,Ziwei He et al.
Aimin Jiang et al.
Background: Tumor-derived exosomes are involved in tumor progression and immune invasion and might function as promising noninvasive approaches for clinical management. However, there are few reports on exosom-based marke...
S100A8 promotes tumor progression by inducing phenotypic polarization of microglia through the TLR4/IL-10 signaling pathway in glioma [0.03%]
S100A8通过TLR4/IL-10信号通路诱导小胶质细胞表型极化促进胶质瘤进展
Yuechao Yang,Huanhuan Cui,Deheng Li et al.
Yuechao Yang et al.
Background: S100A8 is a member of the S100 protein family and plays a pivotal role in regulating inflammation and tumor progression. This study aimed to comprehensively assess the expression patterns and functional roles ...
Editorial note to "Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma" [J Natl Cancer Cent. 2023;3(3):236-249] [0.03%]
《肿瘤微环境为基础的分子标志物可区分透明细胞肾细胞癌的肿瘤异质性、预后和免疫组学特征》一文的编辑后记[J Natl Cancer Cent. 2023;3(3):236-249]
Guidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition) [0.03%]
中国晚期乳腺癌诊断和治疗指南（2022版）
Breast Cancer Expert Committee of National Quality Control Center for Cancer;;Breast Cancer Expert Committee of China Anti-Cancer Association;;Cancer Drug Clinical Research Committee of China Anti-Cancer Ass
Breast Cancer Expert Committee of National Quality Control Center for Cancer;;Breast Cancer Expert Committee of China Anti-Cancer Association;;Cancer Drug Clinical Research Committee of China Anti-Cancer Ass
Breast cancer is the most common cancer among women worldwide. It has been estimated that about 416 000 new cases and over 117 000 deaths of breast cancer occurred in China in 2020. Among the new cases of breast cancer diagnosed each year, ...
Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial [0.03%]
白蛋白结合型紫杉醇与顺铂联合紫杉醇一线治疗卵巢癌疗效和安全性非劣效的多中心开放随机对照研究
Rong Li,Hongping Zhang,Qingshui Li et al.
Rong Li et al.
Background: The paclitaxel liposome formulation, encapsulating paclitaxel within a phospholipid bilayer, addresses the insolubility of traditional paclitaxel formulations, thereby reducing toxicity without compromising it...